Emtricitabine
Emtricitabine is a generic prescription medication used to treat HIV infection. It comes as 200 mg oral capsules, manufactured by Cipla USA Inc. As a nucleoside reverse transcriptase inhibitor, it helps prevent HIV from multiplying in the body. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[ "009:10" ] |
| contactPoint |
{ "fn": "Division of Drug Information", "@type": "vcard:Contact", "hasEmail": "mailto:druginfo@fda.hhs.gov" } |
| description | Emtricitabine is a generic prescription medication used to treat HIV infection. It comes as 200 mg oral capsules, manufactured by Cipla USA Inc. As a nucleoside reverse transcriptase inhibitor, it helps prevent HIV from multiplying in the body. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Emtricitabine", "mediaType": "text/html", "description": " Access the FDA dataset for Emtricitabine — ANDA 208215 submitted by Mylan Institutional LLC ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208215" } ] |
| identifier | ANDA208215 |
| issued | 2016-09-16 |
| keyword |
[ "drug", "drug-manufacturers", "drug-safety", "pharmaceuticals", "public-health" ] |
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[ "009:002" ] |
| publisher |
{ "name": "U.S. Food and Drug Administration", "@type": "org:Organization" } |
| theme |
[ "FDA" ] |
| title | Emtricitabine |
